Our value resides where unmet clinical needs and products needing improvement require immediate attention.
We review both existing off-patent molecules and unique molecular compounds, identifying market need and embracing difficult APIs.
We then consider the in-practice utility, making our agents easier to reconstitute or easier to handle.